Log on / register
Feedback | Support | My details
Dendritic cell defects in patients with cancer: mechanisms and significance.
Lenahan C, Avigan D
Breast Cancer Res 2006, 8:101
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.
37%37%


 Research article    
Ex vivo recovery and activation of dysfunctional, anergic, monocyte-derived dendritic cells from patients with operable breast cancer: critical role of IFN-alpha
Satthaporn S, Aloysius MM, Robins RA, Verma C, Chuthapisith S, Mckechnie AJ, El-Sheemy M, Vassanasiri W, Valerio D, Clark D, Jibril JA, Eremin O
BMC Immunology 2008, 9:32 (27 June 2008)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]
2.
37%37%


 Letter    
The key role of CD40 ligand in overcoming tumor-induced dendritic cell dysfunction
Pinzon-Charry A, Schmidt CW, López JA
Breast Cancer Research 2006, 8:402 (22 February 2006)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

This article is also cited by a further 1 article in PubMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.